Barclays analyst Benjamin Budish maintained a Buy rating on Nasdaq (NDAQ – Research Report) today and set a price target of $95.00. The

Barclays lowered the firm’s price target on Nasdaq (NDAQ) to $95 from $96 and keeps an Overweight rating on the shares post the Q4 report. The

Nextracker (NASDAQ:NXT) shares continue to post big gains, +19.9% in Wednesday's trading after hiking its earnings guidance for the full year, prompting analysts at Barclays to upgrade to Overweight from Equal Weight with a $60 price target,

In a report released today, Betty Jiang from Barclays maintained a Hold rating on APA (APA – Research Report), with a price target of $27.00.

In a report released today, Ramsey El Assal from Barclays maintained a Buy rating on Automatic Data Processing (ADP – Research Report), with a

Barclays (LON:BARC) initiated coverage on Natera shares (NASDAQ:NTRA), currently trading at $171.93, with an Overweight rating and a $200 price target. The stock has demonstrated remarkable momentum,

The broad market is less volatile today, but the big news continue to be tech stocks releasing quarterly earnings. Dow Jones Industrial Average: Up 0.35% Nasdaq: Up 0.04% S&P 500: Up 0.26% Meta Rises,

Number of Hedge Fund Holders: 36 Lumentum Holdings Inc. (NASDAQ:LITE) produces optical and photonic technologies used in cloud data centers, AI/ML applications, and industrial technologies. Barclays upgraded Lumentum (NASDAQ:LITE) to Overweight from ...

In a report released today, Jeff Bernstein from Barclays maintained a Buy rating on Starbucks (SBUX – Research Report), with a price target of

Barclays upgraded Lumentum Holdings Inc (NASDAQ:LITE) to "Overweight" from "Underweight," setting a price target of $125, given significant growth potential driven by surging demand from hyperscale customers.

Lumentum's (NASDAQ:LITE) stock rose about 6% premarket on Friday after Barclays upgraded the shares to Overweight from Underweight. The firm also raised the price target to $125 from $80 on the shares of the company,

Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports.